Duke University Early Phase Research Unit — Durham, North Carolina

Duke University Early Phase Research Unit is a clinical research site located in Durham, North Carolina, United States 27710.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Duke University Early Phase Research Unit has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Glycogen Storage Disease Type II Infantile Onset.

Sponsors: Amicus Therapeutics.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Duke University Early Phase Research Unit?

Duke University Early Phase Research Unit has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Duke University Early Phase Research Unit conducted?

Duke University Early Phase Research Unit has 1 clinical trials on record, with 1 currently active. Their work covers Glycogen Storage Disease Type II Infantile Onset.

Is Duke University Early Phase Research Unit accredited by Crixeo Health?

Duke University Early Phase Research Unit has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Duke University Early Phase Research Unit?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.